May 14, 2020 / 6:14 AM / 20 days ago

BRIEF-Ultimovacs Q1 Operating Loss At NOK 31.3 Million

May 14 (Reuters) - Ultimovacs ASA:

* Q1 OPERATING LOSS NOK 31.3 MILLION VERSUS LOSS NOK 15.0 MILLION YEAR AGO

* Q1 TOTAL OPERATING EXPENSES NOK 31.3 MILLION VERSUS NOK 15.0 MILLION YEAR AGO

* DESPITE TEMPORARY HALT IN CLINICAL TRIALS AT SEVERAL HOSPITALS CAUSED BY COVID-19, FIRST SITE IN INITIUM TRIAL HAS RECENTLY OPENED FOR PATIENT INCLUSION Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below